• Hospital environments are, by definition, important hubs of infectious agents for public health. Theongoing SARS-CoV2 pandemic is the best example of the necessity to develop effective detection and monitoring strategies.
• Moreover, poor infection control programmes in hospitals have enabled Hospital Acquired Infections and have gravely deteriorated the global Antimicrobial Resistance (AMR) epidemic.
• WHO estimates for Europe indicate that the excess mortality due to resistant bacteria in hospital infections exceeds 25,000 annually, with annual costs of at least €1.5billion.
• The problem is further exacerbated by the worldwide spread of Multi-drug Resistant Organisms (MDROs), complicating infection management and limiting treatment options.
Our main goal is to detect and monitor microbial communities located in public and non-public areas of the transportation hubs and to record hotspot areas and transmission patterns.
By constructing almost complete genomes from metagenomic samples, we are able to exhaustively identify all potential biological hazards as well as monitor their spread in hospital environments.
Monitoring pathogens in the environment in almost real time allows targeted and effective infection control measures.
Monitoring the microbial load of hospitals and public health facilities will lead to better strategies for pathogen spread mitigation.
Intensive care units
Benefits of the Health Unit
Identifying and monitoring the microbial footprint of the hospital unit will create a safe environment both for the medical staff and patients
Infection control in hospitals is an important quality indicator for the provided services, contributing to hospitalisation time and costreduction.
The hospital administration will have imminent information of possible health threats and will be able to take the necessary measures
The interactive result reports generated by the DNA sequence Biosafety platform can be used to inform authorities and interested third parties